StonvexLoading…
StonvexStonvexStonvexCore line items from ACNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $19.41M | $74.94M | $56.18M | $36.49M |
Operating Income | $-2.38M | $-7.03M | $-5.54M | $-4.73M |
Net Income | $-1.98M | $867.00K | $1.91M | $3.99M |
EPS (Diluted) | $-0.21 | $0.09 | $0.20 | $0.40 |
Total Assets | $102.61M | $111.94M | $119.89M | $122.58M |
Total Liabilities | $20.97M | $24.95M | $32.80M | $32.86M |
Cash & Equivalents | $47.82M | $57.61M | $58.04M | $60.48M |
Free Cash Flow OCF − CapEx | $-5.85M | $-2.06M | $-1.87M | $-2.56M |
Shares Outstanding | 9.21M | 9.40M | 9.37M | 9.43M |